One year of qualification
Audited Supplier
In This Store
![BENZYL[1-[4-[[(4-FLUOROBENZYL)AMINO]CARBONYL]-5-HYDROXY-1-METHYL-6-OXO-1,6-DIHYDROPYRIMIDIN-2-YL]-1-](https://eimg.pharmasources.com/image/20240312/GOim010zQ3Ye0w9H6yA0Ms8HuhAK9BaWwnEmTuCt.gif!200)
Shandong Dinghao Biotechnology Co., Ltd. specializes in R&D, producing and selling APIs and intermediates. The factory is located in the Heze High-tech Development Zone, covers more than 80,000 square meters.
We have pre-production and large production lines with a research center, which makes us have quite strong R & D and supply capabilities.
Our main products are: Indapamide's intermediates, AZD9291(Osimertinib)'s intermediates, Apixaban's intermediates, Buspirone's intermediates and other intermediates.
Year of Establishment: 2018
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 100-500
Main Competitive Advantages: Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Quality Service
Other Competitive Advantages: We have our own R&D Center. The R&D Center covers an area of 1500m2, with complete procedures, equipment and facilities and perfect functions. It can complete all kinds of synthetic reactions with a volume of 250ml-3000L, also equips with dozens of testing equipments, such as, Shimadzu, Agilent chromatograph and other types. It is equipped with 30 professional R & D personnel, including 1 doctor, 5masters, 1 "Taishan Industry leader", 8 person with intermediate titles.
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
